1. Novartis Ag (20 from 3,923 patents)

2. Novartis Pharmaceuticals Corporation (1 from 19 patents)

3. Novartis Pharma Gmbh (8 patents)

1. 9637468 - Process for manufacturing 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine

2. 9493512 - Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates

3. 9278997 - Processes for the manufacture of macrocyclic depsipeptides and new intermediates

4. 9067978 - Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates

5. 8987413 - Aldehyde acetal based processes for the manufacture of macrocyclic depsipeptides and new intermediates

6. 8614289 - Processes for the manufacture of macrocyclic depsipeptides and new intermediates

7. 8536346 - Process or making N-hydroxy-3[4-[[[2-(2methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide and starting materials therefor

8. 8288566 - Enantioselective synthesis of γ-amino-αβ-unsaturated carboxylic acid derivatives

9. 8198465 - 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors

10. 8138344 - Process for the preparation of rapamycin derivatives

11. 8084487 - Processes for the preparation of 4-oxo-octahydro-indole-1-carbocyclic acid methyl ester and derivatives thereof

12. 8008504 - Process for the synthesis of organic compounds

13. 7989494 - Polymorphs of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide

14. 7906677 - Process for phenylacetic acid derivatives

15. 7781597 - Process for the synthesis of organic compounds